GC Cell and Lukas Biomedical Forge Strategic International Partnership

 GC Cell Corporation (hereinafter referred to as "GC Cell"; 144510:KOSDAQ) and Lukas Biomedical Co., Ltd. (hereinafter referred to as "Lukas," TWSE ...

July 22, 2024 | Monday | News
Understanding the Biosecure Act: Implications for the Pharmaceutical Industry

  The Biosecure Act is a significant legislative proposal aimed at reshaping the pharmaceutical supply chain landscape, particularly concerning the s...

July 21, 2024 | Sunday | Reports
Teva Pharmaceuticals’ AJOVY Achieves Primary End Point in Pediatric Phase 3 Migraine Study

SPACE pediatric Phase 3 study met its primary end point for efficacy with a significantly greater reduction in Monthly Migraine Days compared to ...

July 19, 2024 | Friday | News
Novartis CEO Vas Narasimhan Announces Impressive Q2 2024 Results: 11% Net Sales Surge and Upgraded FY2024 Guidance

net sales grew +11% (cc1, +9% USD) with core operating income up +19% (cc, +17% USD) Sales growth driven by continued strong performance from Entr...

July 18, 2024 | Thursday | Company results
CordenPharma Announces Record €900M Investment to Expand Peptide Platform in US and Europe

CordenPharma is making a record investment of ~€900m over the next 3 years in expanding its peptide platform, both at its Colorado, US site and in...

July 16, 2024 | Tuesday | News
Certara to Acquire Chemaxon, Expanding Biosimulation Capabilities in Drug Discovery

Certara, Inc.  a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire Chemaxon, a leadi...

July 10, 2024 | Wednesday | News
Certara to Acquire Chemaxon, Expanding Biosimulation Capabilities in Drug Discovery

Certara, Inc.  a global leader in model-informed drug development, today announced it has signed a definitive agreement to acquire Chemaxon, a leadi...

July 10, 2024 | Wednesday | News
Apriori Bio Secures $1.1 Million from CEPI to Enhance AI-Driven Vaccine Platform Against Evolving Viruses

Biotechnology company Apriori Bio has been awarded US $1.1 million from CEPI to advance its biology-informed artificial intelligence platform Octavi...

July 09, 2024 | Tuesday | News
Eli Lilly to Acquire Morphic Holding for $3.2 Billion, Expanding Gastroenterology Portfolio

Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF)  announced a definitive agreement for Lilly to acquire Mor...

July 09, 2024 | Tuesday | News
Roche's Vabysmo® Prefilled Syringe Gains FDA Approval for Major Eye Conditions

Roche  announced  that the United States Food and Drug Administration (US FDA) has approved the Vabysmo® (faricimab) 6.0 mg single-dose pre...

July 05, 2024 | Friday | News
Biogen Inc. Completes Acquisition of Human Immunology Biosciences (HI-Bio™)

Biogen Inc. has completed the acquisition of Human Immunology Biosciences (HI-Bio™), a privately-held clinical-stage biotechnology company foc...

July 03, 2024 | Wednesday | News
Samsung Bioepis Receives FDA Approval for PYZCHIVA® as Biosimilar to Stelara for Multiple Inflammatory Conditions

Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for PYZCHIVA&re...

July 01, 2024 | Monday | News
Nxera Pharma Hits Major R&D Milestone in Collaboration with AbbVie, Secures $10 Million Payment

Nxera Pharma  announces that it has reached an important R&D milestone under its multi-target discovery collaboration with AbbVie targeting neur...

June 27, 2024 | Thursday | News
Abzena and Argonaut Forge Strategic Partnership to Transform Biopharmaceutical Manufacturing

Abzena, the leading end-to-end integrated contract and development manufacturing organization (CDMO) for complex biologics and bioconjugates, andArgonaut...

June 24, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close